This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Deep, G. Articles by Agarwal, R. Search for Related Content PubMed PubMed Citation Articles by Deep, G. Articles by Agarwal, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Prostate Cancer Skin Cancer Social Bookmarking                         What's this?

Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer

Department of Pharmaceutical Sciences, School of Pharmacy

Rajesh Agarwal, PhD

Department of Pharmaceutical Sciences, School of Pharmacy, Rajesh.Agarwal{at}UCHSC.edu, University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado

Prevention and therapeutic intervention by phytochemicals are newer dimensions in the arena of cancer management. In this regard, the cancer chemopreventive role of silymarin (Silybum marianum) has been extensively studied and has shown anticancer efficacy against various cancer sites, especially skin and prostate. In skin cancer, silymarin treatment inhibits ultraviolet B radiation or chemically initiated or promoted carcinogenesis. These effects of silymarin against skin carcinogenesis have been attributed to its strong antioxidant and anti-inflammatory action as well as its inhibitory effect on mitogenic signaling. Similarly, silymarin treatment inhibits 3, 2-dimethyl-4-aminobiphenyl—induced prostate carcinogenesis and retards the growth of advanced prostate tumor xenograft in athymic nude mice. In prostate cancer, silymarin treatment down-regulates androgen receptor—, epidermal growth factor receptor—, and nuclear factor-B— mediated signaling and induces cell cycle arrest. Extensive preclinical findings have supported the anticancer potential of silymarin, and now its efficacy is being evaluated in cancer patients.

Key Words: chemoprevention • antioxidant • anti-inflammatory • carcinogenesis • cell cycle • hepatoprotectant

Integrative Cancer Therapies, Vol. 6, No. 2, 130-145 (2007)
DOI: 10.1177/1534735407301441


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Kaur, B. Velmurugan, A. Tyagi, G. Deep, S. Katiyar, C. Agarwal, and R. Agarwal Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft Mol. Cancer Ther., August 1, 2009; 8(8): 2366 - 2374. [Abstract] [Full Text] [PDF]

				R. Agarwal and G. Deep Kava, a Tonic for Relieving the Irrational Development of Natural Preventive Agents Cancer Prevention Research, November 1, 2008; 1(6): 409 - 412. [Full Text] [PDF]

				M. Chittezhath, G. Deep, R. P. Singh, C. Agarwal, and R. Agarwal Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells Mol. Cancer Ther., July 1, 2008; 7(7): 1817 - 1826. [Abstract] [Full Text] [PDF]

				D. J. Kroll, H. S. Shaw, and N. H. Oberlies Milk Thistle Nomenclature: Why It Matters in Cancer Research and Pharmacokinetic Studies Integr Cancer Ther, June 1, 2007; 6(2): 110 - 119. [Abstract] [PDF]

				H. Greenlee, K. Abascal, E. Yarnell, and E. Ladas Clinical Applications of Silybum marianum in Oncology Integr Cancer Ther, June 1, 2007; 6(2): 158 - 165. [Abstract] [PDF]